Literature DB >> 12789237

Differential regulation of eotaxin expression by IFN-gamma in airway epithelial cells.

Satoshi Matsukura1, Fumio Kokubu, Hideki Kuga, Mio Kawaguchi, Koushi Ieki, Miho Odaka, Shintarou Suzuki, Shin Watanabe, Hiroko Takeuchi, Mitsuru Adachi, Cristiana Stellato, Robert P Schleimer.   

Abstract

BACKGROUND: Eotaxin is a chemokine that binds with high affinity and specificity to the chemokine receptor CCR3 and plays an important role in the pathogenesis of allergic disease.
OBJECTIVE: We studied the regulation of eotaxin expression by the T(H)1 cytokine IFN-gamma and analyzed its molecular mechanisms.
METHODS: Levels of eotaxin mRNA and protein expression in the airway epithelial cell line BEAS-2B were determined with RT-PCR and ELISA. Mechanisms of transcriptional regulation were assessed by means of electrophoretic mobility shift assays and luciferase assay with eotaxin promoter-luciferase reporter plasmids.
RESULTS: Although IFN-gamma did not directly induce the expression of eotaxin protein, it increased the induction by TNF-alpha when these cytokines were added simultaneously. In contrast, preincubation of cells with IFN-gamma for 24 hours profoundly inhibited the production induced by TNF-alpha. IFN-gamma did not influence the TNF-alpha-induced binding of nuclear factor kappaB to a DNA probe derived from the eotaxin promoter. IFN-gamma did not increase the ability of TNF-alpha to activate the eotaxin promoter. Studies of eotaxin mRNA levels indicate that IFN-gamma combined with TNF-alpha increased the expression of eotaxin mRNA. When cells were preincubated with IFN-gamma, there was no inhibition of the appearance of eotaxin mRNA.
CONCLUSION: These studies demonstrate that IFN-gamma enhances eotaxin expression when added in combination with TNF-alpha and profoundly inhibits eotaxin expression after preincubation. In both cases the available data indicate that the effect is mediated by a posttranscriptional mechanism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12789237     DOI: 10.1067/mai.2003.1513

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  7 in total

1.  Airway IFN-γ production during RSV bronchiolitis is associated with eosinophilic inflammation.

Authors:  Chang Keun Kim; Zak Callaway; Young Yull Koh; Soo-Hee Kim; Takao Fujisawa
Journal:  Lung       Date:  2011-12-13       Impact factor: 2.584

2.  Genetic interactions model among Eotaxin gene polymorphisms in asthma.

Authors:  June-Hyuk Lee; Jason H Moore; Sung-Woo Park; An-Soo Jang; Soo-Taek Uh; Yong Hoon Kim; Choon-Sik Park; Byung Lae Park; Hyoung Doo Shin
Journal:  J Hum Genet       Date:  2008-08-20       Impact factor: 3.172

3.  Increases in airway eosinophilia and a th1 cytokine during the chronic asymptomatic phase of asthma.

Authors:  Chang Keun Kim; Jungi Choi; Zak Callaway; Koji Iijima; Gerald Volcheck; Hirohito Kita
Journal:  Respir Med       Date:  2010-08-14       Impact factor: 3.415

4.  IFN-γ acts on the airway epithelium to inhibit local and systemic pathology in allergic airway disease.

Authors:  Charlotte Mitchell; Karin Provost; Naiqian Niu; Robert Homer; Lauren Cohn
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

5.  Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.

Authors:  Teresa R Johnson; Marc E Rothenberg; Barney S Graham
Journal:  J Leukoc Biol       Date:  2008-06-02       Impact factor: 4.962

6.  Stimulation of an anti-tumor immune response with "chromatin-damaging" therapy.

Authors:  Minhui Chen; Craig M Brackett; Lyudmila G Burdelya; Achamaporn Punnanitinont; Santosh K Patnaik; Junko Matsuzaki; Adekunle O Odunsi; Andrei V Gudkov; Anurag K Singh; Elizabeth A Repasky; Katerina V Gurova
Journal:  Cancer Immunol Immunother       Date:  2021-01-13       Impact factor: 6.630

7.  Loss of amyloid precursor protein exacerbates early inflammation in Niemann-Pick disease type C.

Authors:  Samuel D Shin; Alexandra Shin; Karina Mayagoitia; Lorraine Siebold; Marsilio Rubini; Christopher G Wilson; Denise L Bellinger; Salvador Soriano
Journal:  J Neuroinflammation       Date:  2019-12-17       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.